Your browser doesn't support javascript.
loading
A Case Report of Acute Onset and Rapid Resolution of Atrioventricular Block After Sugammadex: Is the Autonomic System Involved?
Abdelrahim, Mohamed T; Kassels, Austin C; Stark, Cain W; Roberts, Christopher J; Vogt, Julia A; Ebert, Thomas J.
Affiliation
  • Abdelrahim MT; Department of Anesthesiology, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Kassels AC; Department of Anesthesiology, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Stark CW; From the Department of Anesthesiology, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Roberts CJ; Department of Anesthesiology, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Vogt JA; Department of Anesthesiology, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Ebert TJ; Department of Anesthesiology, Zablocki Veterans Affairs Medical Center, Milwaukee, Wisconsin.
A A Pract ; 17(5): e01683, 2023 May 01.
Article in En | MEDLINE | ID: mdl-37146215
ABSTRACT
Administering sugammadex to reverse neuromuscular blockade can cause marked bradycardia and rarely asystole. In this case, a rapid onset, biphasic heart rate response; slowing then speeding, after administering sugammadex was noted while at steady state, 1.3% end-tidal sevoflurane. On review of the electrocardiogram (ECG), the heart rate slowing coincided with the onset of a second-degree, Mobitz type I block that lasted 45 seconds. No other events, drugs, or stimuli coincided with the event. The acute onset and transient nature of the atrioventricular block without evidence of ischemia implies a brief parasympathetic effect on the atrioventricular node after sugammadex administration.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neuromuscular Nondepolarizing Agents / Gamma-Cyclodextrins / Atrioventricular Block Limits: Humans Language: En Journal: A A Pract Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neuromuscular Nondepolarizing Agents / Gamma-Cyclodextrins / Atrioventricular Block Limits: Humans Language: En Journal: A A Pract Year: 2023 Document type: Article